Log In
Print this Print this

FFP104 (formerly PG102)

  Manage Alerts
Collapse Summary General Information
Company PanGenetics B.V.
DescriptionDeimmunized mAb against CD40
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today